单核苷酸多态性与原发性肝癌易感性及临床病理学的相关分析
Correlation Analysis of Single Nucleotide Polymorphism with Susceptibility and Clinicopathology of Primary Hepatic Carcinoma
摘要: 目的:探讨单核苷酸多态性(SNP)与本地区原发性肝癌(PHC)遗传易感性的关系,并探究SNP位点数目与肝癌患者临床病理学的相关性。方法:采用聚合酶链反应–限制性片段长度多态性技术检测234例肝癌患者和234例阴性对照的27个PHC相关SNP位点基因型和等位基因分布频率,并分析SNP位点与PHC遗传易感性、肝癌患者临床病理学和SNP位点数目的相关性。结果:1) miR-34b/c基因rs4938723位点CC基因型(调整OR = 1.736,95%CI:1.036~2.910,P = 0.036)、EGF基因rs4444903位点GG基因型(调整OR = 1.841,95%CI:1.103~3.071,P = 0.019)具有更高的PHC患病风险;KIF1B基因rs17401966位点GG基因型具有更低的PHC患病风险(调整OR = 0.540,95%CI:0.314~0.930,P = 0.026);分层分析结果显示在男性(P = 0.039)和饮酒(P = 0.025)的人群中EGF基因rs4444903位点基因型GG相比AA + AG基因型PHC发病风险增加;在女性(P = 0.013)、年龄 < 60岁(P = 0.026)及不饮酒(P = 0.039)人群中KIF1B基因rs17401966位点GG基因型相比AA + AG基因型PHC发病风险降低。2) SNP位点数目与门静脉癌栓发生率增加有关(调整OR = 1.122,95%CI:1.005~1.251,P = 0.040)。结论:miR-34b/c基因rs4938723、EGF基因rs4444903、KIF1B基因rs17401966单核苷酸多态性与本地区PHC风险相关,SNP位点数目与肝癌患者临床病理学具有相关性。
Abstract: Objective: To investigate the relationship between single nucleotide polymorphism (SNP) and ge-netic susceptibility to primary hepatic carcinoma (PHC) in local population, and to explore the cor-relation between the number of SNPs and clinicopathology in patients with PHC. Methods: Poly-merase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to detect the genotype and allele distribution frequency of 27 PHC-associated SNPs in 234 hepatocellular car-cinoma patients and 234 negative controls, and to analyze the correlation between SNPs and genet-ic susceptibility to PHC, clinicopathology of hepatocellular carcinoma patients and the number of SNPs. Results: 1) The miR-34b/c gene loci rs4938723 CC genotype (adjusted OR = 1.736, 95%CI; 1.036~2.910, P = 0.036) and EGF gene loci rs4444903 GG genotype (adjusted OR = 1.841, 95%CI; 1.103~3.071, P = 0.019) had a higher risk of PHC. The KIF1B gene loci rs17401966 GG genotype (adjusted OR = 0.540, 95%CI; 0.314~0.930, P = 0.026) had lower risk of PHC. The stratification analysis showed that EGF rs4444903 GG genotype had a higher risk than AA + AG genotype in male (P = 0.039), and alcoholic population (P = 0.025), KIF1B rs17401966 GG genotype had a lower risk than AA + AG genotype in female (P = 0.013), age < 60 years (P = 0.026) and non-alcoholic popula-tion (P = 0.039). 2) More SNPs resulted in higher incidence of portal vein carcinoma thrombosis (adjusted OR = 1.122, 95%CI; 1.005~1.251, P = 0.040). Conclusion: Single nucleotide polymor-phisms in miR-34b/c gene rs4938723, EGF gene rs4444903, and KIF1B gene rs17401966 were asso-ciated with PHC risk in the region, and the number of SNPs correlated with clinicopathology in pa-tients with hepatocellular carcinoma.
文章引用:唐豪言, 潘正龙, 荣翔, 王小磊, 刘小方. 单核苷酸多态性与原发性肝癌易感性及临床病理学的相关分析[J]. 临床医学进展, 2023, 13(4): 5193-5204. https://doi.org/10.12677/ACM.2023.134736

参考文献

[1] 何凤蝶, 王秋童, 胡亚男, 等. 中国人群肝癌发病危险因素病例对照研究的meta分析[J]. 现代预防医学, 2022, 49(23): 4230-4240.
[2] Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[3] Chen, W., Sun, K., Zheng, R., et al. (2018) Cancer Incidence and Mortality in China, 2014. Chinese Journal of Cancer Research, 30, 1-12. [Google Scholar] [CrossRef] [PubMed]
[4] Li, Y., Zhang, F. and Yang, D. (2017) Comprehensive Assessment and Meta-Analysis of the Association between Ctnnb1 Polymorphisms and Cancer Risk. Bioscience Re-ports, 37, 432-440. [Google Scholar] [CrossRef
[5] 沈影, 夏霁, 韩凤娟. 基因单核苷酸多态性在卵巢癌精准医疗中的应用探析[J]. 中南药学, 2020, 18(4): 627-629.
[6] 周泽文, 张若昕, 魏庆义, 等. 肝细胞癌全基因组关联分析研究进展及展望[J]. 中国癌症防治杂志, 2020, 12(1): 6-13.
[7] Wang, C., Lu, D., Ling, Q., et al. (2019) Donor Onecarbon Metabolism Gene Single Nucleotide Polymorphisms Predict the Susceptibility of Cancer Re-currence after Liver Transplantation. Gene, 68, 97-101. [Google Scholar] [CrossRef] [PubMed]
[8] 杨怡, 席子涵, 张林颖. 极光激酶B、肿瘤蛋白53在肝细胞癌中的表达及与临床病理特征、预后的关系[J]. 肝脏, 2022, 27(2): 188-192.
[9] Le, P.H., Kuo, C.J., Hsieh, Y.C., et al. (2019) Ages of Hepatocellular Carcinoma Occurrence and Life Expectancy Are Associated with a UGT2B28 Ge-nomic Variation. BMC Cancer, 19, Article No. 1190. [Google Scholar] [CrossRef] [PubMed]
[10] Huang, Z., Guo, X., Zhang, G., et al. (2019) Correlation between PNPLA3 rs738409 Polymorphism and Hepatocellular Carcinoma: A Meta-Analysis of 10,330 Subjects. The Interna-tional Journal of Biological Markers, 34, 117-122. [Google Scholar] [CrossRef] [PubMed]
[11] 陆小华, 朱小庆, 袁洪新, 等. APE1基因单核苷酸多态性与肝细胞癌临床表型的相关性研究[J]. 中国当代医药, 2020, 27(13): 13-17.
[12] Liu, W., Ma, N., Zhao, D., et al. (2019) Correlation between the DEPDC5 rs1012068 Polymorphism and the Risk of HBV-Related Hepatocellular Carci-noma. Clinics and Research in Hepatology and Gastroenterology, 43, 446-450. [Google Scholar] [CrossRef] [PubMed]
[13] Xu, B., Zhu, Y., Tang, Y., Zhang, Z., et al. (2018) Rs4938723 Polymorphism Is Associated with Susceptibility to Hepatocellular Carcinoma Risk and Is a Protective Factor in Leuke-mia, Colorectal, and Esophageal Cancer. Medical Science Monitor, 24, 7057-7071. [Google Scholar] [CrossRef
[14] Hashemi, M., Moazeni-Roodi, A., Bahari, G., et al. (2019) Associa-tion between miR-34b/c rs4938723 Polymorphism and Risk of Cancer: An Updated Meta-Analysis of 27 Case-Control Studies. Journal of Cellular Biochemistry, 120, 3306-3314. [Google Scholar] [CrossRef] [PubMed]
[15] Liu, Q., Yang, G., Song, X.L., et al. (2015) Association between rs4938723 Functional Polymorphism in the Promoter Region of miR-34b/c Gene and Cancer Risk. Clinics and Research in Hepatology and Gastroenterology, 39, 526-533. [Google Scholar] [CrossRef] [PubMed]
[16] Zhu, Y., Chen, Z., Jiang, H., et al. (2019) The Genetic Associa-tion between EGF A61G Polymorphism (rs4444903) and Risk of Colorectal Cancer: An Update Meta-Analysis and Trial Sequential Analysis. Medicine, 98, e14007. [Google Scholar] [CrossRef
[17] Laus, A.C., De Paula, F.E., De Lima, M.A., et al. (2019) EGF+61 A>G Polymorphism Is Not Associated with Lung Cancer Risk in the Brazilian Population. Molecular Biology Reports, 46, 2417-2425. [Google Scholar] [CrossRef] [PubMed]
[18] Jiang, G., Yu, K., Shao, L., et al. (2015) Association between Epidermal Growth Factor Gene +61A/G Polymorphism and the Risk of Hepatocellular Carcinoma: A Meta-Analysis Based on 16 Studies. BMC Cancer, 15, Article No. 314. [Google Scholar] [CrossRef] [PubMed]
[19] Li, Y.L., Tian, Z., Zhao, L., et al. (2014) Association between the EGF rs4444903 Polymorphism and Liver Cancer Susceptibility: A Meta-Analysis and Meta-Regression. Genetics and Molecular Research, 13, 8066-8079. [Google Scholar] [CrossRef
[20] Wang, J., Zhong, Y. and Meng, G. (2021) EGF rs4444903 Poly-morphism Is Associated with Risk of HCV-Related Cirrhosis and HBV/HCV-Related Hepatocellular Carcinoma. Inter-national Journal of Clinical Oncology Volume, 26, 2053-2064. [Google Scholar] [CrossRef] [PubMed]
[21] Zhang, Y.F., Zeng, X.L., Lu, H.W., et al. (2018) Association between KIF1B (rs17401966) Polymorphism and Hepatocellular Carcinoma Susceptibility: A Meta-Analysis. OncoTar-gets and Therapy, 11, 3225-3235. [Google Scholar] [CrossRef
[22] Wang, Z.C., Gao, Q., Shi, J.Y., et al. (2013) Genetic Polymorphism of the Kinesin-Like Protein KIF1B Gene and the Risk of Hepatocellular Carcinoma. PLOS ONE, 8, 62571-62573. [Google Scholar] [CrossRef] [PubMed]
[23] Luo, Y.Y., Zhang, H.P., Huang, A.L., et al. (2019) Association between KIF1B rs17401966 Genetic Polymorphism and Hepatocellular Carcinoma Susceptibility: An Updated Me-ta-Analysis. BMC Medical Genetics, 20, Article No. 59. [Google Scholar] [CrossRef] [PubMed]
[24] Hsieh, M.C., Hsu, H.T., Hsiao, P.C., et al. (2014) Role of VEGF-C Gene Polymorphisms in Susceptibility to Hepatocellular Carcinoma and Its Pathological Development. Journal of Clinical Laboratory Analysis, 28, 237-244. [Google Scholar] [CrossRef] [PubMed]
[25] Zhang, J., Liu, L., Lin, Z., et al. (2019) SNP-SNP and SNP-Environment Interactions of Potentially Functional Hotair SNPs Modify the Risk of Hepatocellular Carcinoma. Molecular Carcino-genesis, 58, 633-642. [Google Scholar] [CrossRef] [PubMed]
[26] 范余娟, 孙丹, 徐红, 等. 子宫内膜癌组织BRCCA1单核苷酸多态性与临床病理因素相关性分析[J]. 中华肿瘤防治杂志, 2015, 22(16): 1283-1286.
[27] 樊菁, 吕勇刚, 赵戈, 等. 甲状腺乳头状癌BRAFV600E、NRAS、TERT基因的突变特征及其与临床病理特征的相关性[J]. 现代肿瘤医学, 2021, 29(5): 769-773.
[28] Yuan, F., Shi, M., Ji, J., et al. (2014) KRAS and DAXX/ATRX Gene Mutations Are Correlated with the Clinicopathological Features, Advanced Diseases, and Poor Prognosis in Chinese Patients with Pancreatic Neu-roendocrine Tumors. International Journal of Biological Sciences, 10, 957-965. [Google Scholar] [CrossRef] [PubMed]
[29] 张冉, 杨洁, 冯恩梓, 等. 甲状腺乳头状癌基因突变与其侵袭性相关性研究[J]. 昆明医科大学学报, 2023, 44(2): 125-132.
[30] 林晓, 董文韬, 赖霄晶, 等. 晚期非小细胞肺癌ctDNA检测及其临床意义的研究[J]. 世界最新医学信息文摘, 2018, 18(99): 18-20.
[31] 贺佳子, 黄清洁, 李莉, 等. 396例非小细胞肺癌EGFR, KRAS, ALK和BRAF基因突变状态及其临床病理特征[J]. 临床与病理杂志, 2020, 40(9): 2252-2258.